InvestorsHub Logo
icon url

jedijazz

05/13/22 8:02 AM

#12354 RE: JediMozart #12353

Great news. Here's a list of the Conference Call Topics:

Potential investment infusion;
Further developments on FDA Pre-IND application #150335 for Escozine as a COVID-19 treatment;
Lobbying to the FDA;
Update on Dominican Republic controlled double-blind clinical strategy for Escozine as a COVID-19 treatment;
Mexico importation and distribution of Escozine, and clinical strategy and preparation for a study on Escozine as a COVID-19 treatment;
The Company’s name and stock symbol change status;
Changes to the Company’s executive management and corporate control;
Additional distribution opportunities;
Implementation of new sales and marketing strategies;
Collaborative opportunities with large pharmaceutical companies;
Change in the Company’s independent auditing firm;
Addressing recent concerns from shareholders; $QNTA